Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 639 for “"HDAC"”.
-
Development Of Elisa-Based Hdac Activity Assay For Identification Of Isoform Selective Hdac Inhibitors
… drugs that inhibit histone deacetylase (HDAC) proteins. HDACs are histone modifying enzymes that regulate transcription of genes. Aberrant recruitment of HDACs to the transcription factors leads to tumor onset and growth. Because of their potential anti-cancer therapeutic interest, …
-
Investigating HDAC-MEF2 Roles in Osteoclastogenesis
… previous research showing histone deacetylase 7 (HDAC7) repressed osteoclast differentiation. I found that overexpression of a fragment of HDAC7 that interacts with the myocyte enhancer factor 2 (MEF2) family of transcription factors repressed osteoclast differentiation to a similar degree as the …
-
HR23B, a biomarker for HDAC inhibitors
… through targeting histone deacetylase (HDAC) has led to the introduction of many HDAC inhibitors. To date, two have had regulatory approval for the treatment of cutaneous T cell lymphoma (CTCL). Modifications in chromatin control underpin the mechanism of action of HDAC inhibitors. A …
-
Effects of HDAC inhibitors in human diseases.
Contains fulltext : 91753.pdf (Publisher’s version ) (Open Access)
-
Rolle der Histondeacetylase (HDAC) in humanen soliden Tumoren
… charakterisiert und die Effekte zweier bekannter HDAC-Inhibitoren im Zellkulturmodell untersucht. Eine vermehrte Expression einzelner HDAC-Isoformen war mit einer verstärkten Proliferation und Dedifferenzierung der Tumoren assoziiert und stellte in einigen Tumorentitäten einen unabhängigen …
-
An improved synthesis of the HDAC inhibitor trichostatin A
Histone deacetylase inhibitors (HDIs) have found a wide variety of medicinal uses and are most noted for their specific apoptotic action towards cancer cells. Several hydroxamate HDIs have since been moved on to phase 1 and 2 clinical drug trials, with one having already been approved for treatment …
-
Structural and binding characterization of dual BET/HDAC inhibitors
… and Extra Terminal) των bromodomains και οι HDAC (Histone deacetylases), αντίστοιχα. Ο κρίσιμος ρόλος τους σε πολλαπλές κυτταρικές διεργασίες και κατ’ επέκταση η διαταραγμένη έκφραση και λειτουργία τους εμπλέκονται σε μια πληθώρα παθολογιών – συχνά επικαλυπτόμενων για τις δύο αυτές κατηγορίες …
-
MEF2 and HDAC Proteins Regulate Striated Muscle Development and Remodeling
… crest cells. Class II histone deacetylase (HDAC) proteins bind to MEF2 and regulate MEF2 activity in response to various signaling cascades. To understand the role of MEF2 and class II HDAC proteins in skeletal muscle development and remodeling, we analyzed individual MEF2 knockout mice, …
-
Trapping Mutants To Discover The Substrate Preference Of Hdac Enzymes
… and histone deacetylases. Histone deacetylases (HDAC) catalyze the removal of acetyl group from the Ɛ-N of acetylated lysine residues in histone tails to form a tight chromatin structure to suppress gene expression. HDAC proteins are linked with many biological functions, cause various diseases, …
-
Synthesis of novel potential HDAC inhibitors based on multicomponent reactions
Multicomponent reactions (MCRs) provide valuable opportunities for the synthesis of a wide range of heterocyclic compounds, many of which exhibit significant biological activity and unique physical properties. Compared with traditional step-by-step synthetic methods, MCRs represent a powerful tool …
-
Isoform-Selective HDAC Inhibition for the Treatment of Lupus Nephritis
… to contribute to disease. Histone deacetylases (HDACs) are a class of enzymes that hydrolyze the lysine bound acetyl group in both histone and non-histone proteins thereby altering protein structure and function. While the use of pan-HDAC inhibitors has proven to be effective for the treatment of …
-
Depletion of Dormant Hormone-Sensitive Breast Cancer Cells Using HDAC Inhibitors
… models, we identified a histone deacetylase (HDAC)-mediated epigenetic vulnerability that enables selective targeting of CSPs under ET conditions. Live-cell imaging confirmed the direct killing of CSPs, while protein expression studies revealed that HDAC inhibition disrupts the balance of pro- …
-
Design, Synthesis, And Evaluation Of Class Iia Histone Deacetylase (hdac) Inhibitors
Histone deacetylase (HDAC) proteins are linked to disease states, including cancer, and have become important targets for therapeutic development. Many inhibitors have been developed to target HDAC proteins, including FDA-approved inhibitors Vorinostat (SAHA), Belinostat, Romidepsin, and …
-
Targeting Histone Deacetylases (Hdac) For The Treatment of Soft Tissue Sarcoma
Targeting Histone deacetylases (HDAC) for the treatment of genetically complex soft tissue sarcoma Histone deactylase inhibitors (HDACi) are a new class of anticancer therapeutics; however, little is known about HDACi or the individual contribution of HDAC isoform activity in soft tissue sarcoma …
-
Therapeutic Potential of Selected HDAC Targeting in Mature T-cell Neoplasms
… the therapeutic potential of selected HDAC-targeting strategies in mature T-cell neoplasms, with a particular focus on T-prolymphocytic leukemia (T-PLL). It examines the biological and therapeutic effects of HDAC inhibitors and combination approaches in relevant cellular models. The …
-
Genomic Analysis of Chemo-Resistance to HDAC inhibitor in Gastric Cancer cells
Histone deacetylase inhibitors (HDACis) are a promising class of anticancer epigenetic drugs, however, molecular factors influencing the responses of individual tumors to HDACi therapies remain obscure. Here, we sought to identify genes associated with HDACi resistance in gastric cancer. Treating a …
-
The Design, Synthesis, And Biological Evaluation Of Selective Histone Deacetylase (hdac) Inhibitors
Histone deacetylase (HDAC) proteins have become an important target for the treatment of several diseases including cancers, neurodegenerative diseases and inflammatory diseases. Four such inhibitors are approved by the FDA as anti-cancer drugs, but unfortunately, they inhibit numerous HDAC …
-
Development Of Novel Radiotracers For Pet Imaging Of Hdac-Mediated Epigenetic Regulation
… transferases (HATs) and histone deacetylases (HDACs), respectively. To date, the vast majority of studies on epigenetic regulation have been conducted in cell cultures and tissue samples using conventional methodologies of molecular and cellular biology, which contain inherent limitations for …
-
Integration of class 1 HDAC inhibitors into current treatments for prostate cancer
… regulators, including histone deacetylases (HDAC), are commonly mutated and highly expressed in cancer, representing attractive clinical targets. Although five HDAC inhibitors (HDACi) have been FDA approved for myelodysplastic syndromes, evaluation of pan-HDACi in CaP clinical trials as …
Page 1 of 32